文献速递焦虑、强迫与应激相关障碍

mPFC中NMDAR正向调节减少恐惧自发恢复

Positive modulation of N-methyl-D-aspartate receptors in the mPFC reduces the spontaneous recovery of fear.
PubMed 文献 · Mol Psychiatry · 2022-04-14

该临床前研究在雄性小鼠的听觉恐惧条件化模型和单次延长应激模型中测试新型NMDAR正向调节剂NYX-783,发现其显著减少两种模型的自发恢复,并在SPS模型中增强恐惧消退。机制上,NYX-783增加IL mPFC兴奋性和抑制性神经元的NMDA诱导内流,其行为效应依赖IL mPFC锥体神经元GluN2B亚基及下游BDNF表达。

要点

  • NYX-783在两种PTSD rodent模型中减少恐惧自发恢复。
  • NYX-783在SPS模型中增强恐惧消退。
  • 效应依赖IL mPFC锥体神经元GluN2B和下游BDNF表达。

核心结论

  • NYX-783可能具有PTSD治疗潜力,尤其可能有助于抑制恐惧自发恢复。

研究设计与样本

  • 在雄性小鼠的听觉恐惧条件化模型和单次延长应激模型两种PTSD rodent模型中测试NYX-783。

主要发现

  • NYX-783给药显著减少两种PTSD模型的自发恢复。
  • NYX-783在SPS模型中增强恐惧消退。
  • NYX-783增加IL mPFC兴奋性和抑制性神经元的NMDA诱导内向电流。
  • IL mPFC锥体神经元NMDAR的GluN2B亚基是其影响自发恢复所必需的。
  • 下游BDNF表达是NYX-783实现行为效应所必需的。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

N-methyl-D-aspartate receptor (NMDAR) modulators have recently received increased attention as potential therapeutics for posttraumatic stress disorder (PTSD). Here, we tested a novel NMDAR-positive modulator, NYX-783, in the following two rodent models of PTSD: an auditory fear-conditioning model and a single-prolonged stress (SPS) model. We examined the ability of NYX-783 to reduce subsequent fear-based behaviors by measuring enhanced fear extinction and reduced spontaneous recovery (spontaneous return of fear) in male mice. NYX-783 administration significantly reduced spontaneous recovery in both PTSD models and enhanced fear extinction in the SPS model. Furthermore, NYX-783 increased the NMDA-induced inward currents of excitatory and inhibitory neurons in the infralimbic medial prefrontal cortex (IL mPFC) and that the GluN2B subunit of NMDARs on pyramidal neurons in the IL mPFC is required for its effect on spontaneous recovery. The downstream expression of brain-derived neurotrophic factor was required for NYX-783 to achieve its behavioral effect. These results elucidate the cellular targets of NYX-783 and the molecular mechanisms underlying the inhibition of spontaneous recovery. These preclinical findings support the hypothesis that NYX-783 may have therapeutic potential for PTSD treatment and may be particularly useful for inhibiting spontaneous recovery.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Lee B, Pothula S, Wu M, et al. Positive modulation of N-methyl-D-aspartate receptors in the mPFC reduces the spontaneous recovery of fear. Mol Psychiatry. 2022. PMID: 35418600. doi:10.1038/s41380-022-01498-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。